Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Barbara Koumaras, BA
PCC
Original Research
Long-Term Safety and Tolerability of Rivastigmine in Patients With Alzheimer's Disease Switched From Donepezil: An Open-Label Extension Study
October 15, 2008
Gary S. Figiel
,
Barbara Koumaras
,
Xiangyi Meng
, et al
PCC
Original Research
Safety and Efficacy of Rivastigmine in Patients With Alzheimer's Disease Not Responding Adequately to Donepezil: An Open-Label Study
August 15, 2008
Gary S. Figiel
,
Carl H. Sadowsky
,
John Strigas
, et al
PCC
Original Research
Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study
April 1, 2005
Carl H. Sadowsky
,
Martin R. Farlow
,
Leone Atkinson
, et al
